159
Participants
Start Date
March 16, 2022
Primary Completion Date
April 3, 2023
Study Completion Date
April 21, 2023
SEPO®
SEPO® will be administered per dose and schedule specified in the arm description.
Roxadustat
Roxadustat will be administered per dose and schedule specified in the arm description.
Affiliated Hospital of Hebei University, Baoding
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing
Capital Medical University Chest Hospital, Beijing
Peking University Cancer Hospital, Beijing
Jilin Cancer Hospital, Changchun
Hunan Cancer Hospital, Changsha
Sichuan Cancer Hospital, Chengdu
Chongqing Bishan People's Hospital, Chongqing
The Second Affiliated Hospital of Third Military Medical University (Xinqiao Hospital), Chongqing
Deyang People's Hospital, Deyang
The First People's Hospital of Foshan, Foshan
Fujian Medical University Union Hospital, Fuzhou
Sun Yat-sen Memorial Hospital, Sun Yat-sen University - Gynecologic Oncology Department, Guangzhou
Sun Yat-sen Memorial Hospital, Sun Yat-sen University - Oncology Department, Guangzhou
Hangzhou Cancer Hospital, Hangzhou
Zhejiang Cancer Hospital, Hangzhou
Harbin Medical University Cancer Hospital, Harbin
Anhui Cancer Hospital, Hefei
Jiangxi Cancer Hospital, Jiangxi
Shandong First Medical University Cancer Hospital, Jinan
The Second Hospital of Lanzhou University, Lanzhou
Jiangsu Province Hospital, Nanjing
The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning
Neijiang Second People's Hospital, Neijiang
Ningbo First Hospital, Ningbo
Jiangxi Pingxiang People's Hospital, Pingxiang
The Affiliated Hospital of Qingdao University, Qingdao
Fudan University Shanghai Cancer Center, Shanghai
Shanghai Chest Hospital, Shanghai
Shanghai Fifth People's Hospital, Shanghai
Liaoning Cancer Hospital & Institute, Shenyang
The First Hospital of China Medical University - Oncology Department Breast Cancer Group, Shenyang
The First Hospital of China Medical University - Oncology Department Lung Cancer Group, Shenyang
Peking University Shenzhen Hospital, Shenzhen
Shanxi Cancer Hospital, Taiyuan
Union Hospital Tongji Medical College, Huazhong University of Science and Technology, Wuhan
University of Science and Technology, Wuhan
Wuhan Fourth Hospital, Wuhan
The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an
Cancer Hospital of Xinjiang Medical University, Xinjiang
Xuzhou Central Hospital, Xuzhou
Yantai Yuhuangding Hospital, Yantai
General Hospital of Ningxia Medical University, Yinchuan
Henan Cancer Hospital, Zhengzhou
Zhuzhou Central Hospital, Zhuzhou
Lead Sponsor
FibroGen
INDUSTRY